News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Formerly CRF Health and Bracket, Signant Health has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as clinical vice president, internal medicine. In this role, Everhart will report the chief medical officer, Dr. David Daniel.
Everhart is Board-certified in internal medicine and a Fellow of the American College of Physicians. He has more than 23 years of experience practicing medicine and over 12 in clinical development.
Previously, Everhart held positions of vice president, medical affairs and vice president, medical informatics at Chiltern and Covance. More recently, he was an independent consultant.
“My goal is to bring Signant’s rater training quality assurance and blinded data analytics into new therapeutic areas such as dermatology, immune-mediated diseases, and cardiorespiratory diseases,” Everhart told us.
“There is also an increasing emphasis on patient-centered outcomes in oncology trials and the application of these methodologies to oncology outcome measures beyond tumor response and survival is mostly unexplored.
“It will be exciting to lead Signant in identifying new applications for our endpoint reliability solutions in these new therapy areas, as well as the challenging and rapidly growing oncology field.”